An innovative new wound care technology will now allow veterinarians in the Baltic countries to protect wounds from bacterial infections and heal animal wounds faster. Amferia announced a distribution partnership with Magnum Veterinaaria—a major player serving the animal health market in Baltic States of Latvia, Lithuania, and Estonia.
The joint efforts will aim to make products available as soon as the spring of 2026.
The partnership with Magnum will bring a groundbreaking wound care to animal patients in the Baltics. Extensive research across Europe demonstrates that Amferia’s dressing helps heal wounds significantly faster than currently available dressings.
But Amferia’s greatest promise might lie in its proven ability to counter the rising threat of antibiotic-resistant bacteria. Because Amferia disrupts bacteria by drawing them close and physically puncturing their cell membranes, even bacterial strains that have developed a resistance to medical antibiotics cannot effectively resist this interaction.
Fueling Growth Across Veterinary Wound Care
According to Amferia Sales and Marketing Director and co-founder Saba Atefyekta, the new partnership will help Magnum advance its animal wound care offerings, as well as expand Amferia’s animal-health footprint in Europe, where its products are already available in Scandinavia, Germany, Spain and Switzerland.
“Magnum’s market leadership in animal health will spearhead Amferia’s vision of addressing antibiotic-resistant wound infections. This partnership brings our innovation together with a leading partner in a market in need of new solutions. Veterinarians across Europe have shown strong interest in our innovation. They immediately recognize the potential for our new antimicrobial material for wound and infection management,” Atefyekta said.
“We’re thrilled to announce that Magnum Veterinaaria is taking wound care in the Baltic region to the next level with the launch of Amferia—a truly unique solution,” said Lina Skinkė Head of Baltic Medicine and Laboratory Division, Magnum Veterinaaria. “This breakthrough technology helps to reduce the reliance on antibiotics in veterinary practice, empowers our partners and their patients to heal faster and more effectively.”
